Abiopharma

(19% Negative) BIGCOMMERCE HOLDINGS, INC. (CMRC) Reports Q2 2026 Financial Results

(90% Positive) ENGENE HOLDINGS INC. (ENGNW) Announces Clinical Development Update

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

(90% Positive) ARMATA PHARMACEUTICALS, INC. (ARMP) Provides Update on need for AP-SA02 Enables more frequent FDA engagement

(99% Positive) REGAL REXNORD CORP (RRX) Reports Q2 2026 Financial Results

(10% Negative) IRONWOOD PHARMACEUTICALS INC (IRWD) Reports Q2 2026 Financial Results

(30% Negative) XOMETRY, INC. (XMTR) Reports Q2 2026 Financial Results

(90% Positive) SCHOLAR ROCK HOLDING CORP (SRRK) Announces Enrollment Update for supply Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(30% Negative) NEUMORA THERAPEUTICS, INC. (NMRA) Reports Q2 2026 Financial Results

Entrada Therapeutics Reports First Quarter 2026 Financial Results

(10% Negative) ALLEGRO MICROSYSTEMS, INC. (ALGM) Reports Q2 2026 Financial Results

New Form SCHEDULE 13G/A - Wix.com Ltd. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001088875-26-000036 <b>Size:</b> 7 KB

(30% Negative) AAON, INC. (AAON) Reports Q2 2026 Financial Results

(30% Negative) KIMBELL ROYALTY PARTNERS, LP (KRP) Reports Q2 2026 Financial Results

(30% Negative) BEAM THERAPEUTICS INC. (BEAM) Reports Q2 2026 Financial Results